Home
→
Researchers
→

Christophe Le Tourneau

Researcher

Christophe Le Tourneau

Persistent identifiers

References for this unit in public registries: they allow cross-checking with other sources and do not change when the name does.

Affiliation

Fields of expertise

cetuximab
Pembrolizumab
head and neck squamous cell carcinoma
head and neck
metastatic
squamous cell carcinoma
immunotherapy
locally advanced

12 publications in HAL since 2022.

Data provenance

Sources : scanR, HAL. Data compiled on 27/10/2026. Found an error? It is corrected in the original source (HAL, RNSR, directory); see how.